{"component": "definition", "props": {"groups": [{"size": 9, "samples": [{"hash": "aY5rT5HDEMS", "uri": "https://www.sec.gov/Archives/edgar/data/1817760/000155837025007572/smtk-20250331xex3d1.htm", "label": "Certificate of Incorporation (SmartKem, Inc.)", "score": 24.3620815277, "published": false}, {"hash": "i8z3dvxcrWJ", "uri": "https://www.sec.gov/Archives/edgar/data/1817760/000155837025004151/smtk-20241231xex3d1.htm", "label": "Certificate of Incorporation (SmartKem, Inc.)", "score": 24.2443523407, "published": false}, {"hash": "6iRvbeFGvb1", "uri": "https://www.sec.gov/Archives/edgar/data/1817760/000155837024011895/smtk-20240630xex3d1.htm", "label": "Certificate of Incorporation (SmartKem, Inc.)", "score": 23.6119098663, "published": false}], "snippet": "means a proposal to amend the Corporation\u2019s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the outstanding shares of Common Stock at a ratio of between one for thirty (1:30) and one for sixty (1:60) with the specific ratio to be determined by the Board of Directors in its reasonable discretion, primarily for the purpose of satisfying any minimum bid price or closing price requirements applicable to the Common Stock in connection with the Uplisting.", "snippet_links": [{"key": "a-proposal", "type": "clause", "offset": [6, 16]}, {"key": "to-amend", "type": "definition", "offset": [17, 25]}, {"key": "the-corporation", "type": "clause", "offset": [26, 41]}, {"key": "amended-and-restated-certificate-of-incorporation", "type": "definition", "offset": [44, 93]}, {"key": "reverse-stock-split", "type": "clause", "offset": [106, 125]}, {"key": "outstanding-shares-of-common-stock", "type": "definition", "offset": [133, 167]}, {"key": "ratio-of", "type": "clause", "offset": [173, 181]}, {"key": "to-be-determined", "type": "definition", "offset": [261, 277]}, {"key": "by-the-board-of-directors", "type": "clause", "offset": [278, 303]}, {"key": "reasonable-discretion", "type": "clause", "offset": [311, 332]}, {"key": "for-the-purpose-of", "type": "definition", "offset": [344, 362]}, {"key": "minimum-bid-price", "type": "definition", "offset": [378, 395]}, {"key": "closing-price", "type": "clause", "offset": [399, 412]}, {"key": "applicable-to", "type": "clause", "offset": [426, 439]}, {"key": "the-common-stock", "type": "clause", "offset": [440, 456]}, {"key": "in-connection-with", "type": "clause", "offset": [457, 475]}], "hash": "51df224757da0eb427274c14f04dc716", "id": 1}, {"size": 6, "samples": [{"hash": "gboVi88OIsG", "uri": "/contracts/gboVi88OIsG#reverse-stock-split-proposal", "label": "Restructuring Support Agreement (5E Advanced Materials, Inc.)", "score": 35.036277771, "published": true}, {"hash": "bBEywNEnwRu", "uri": "/contracts/bBEywNEnwRu#reverse-stock-split-proposal", "label": "Restructuring Support Agreement (5E Advanced Materials, Inc.)", "score": 35.036277771, "published": true}, {"hash": "aRq4354E64v", "uri": "https://www.aspecthuntley.com.au/asxdata/20250115/pdf/02903231.pdf", "label": "www.aspecthuntley.com.au", "score": 19.9208374023, "published": false}], "snippet": "means the proposal to be presented at the Company\u2019s 2024 annual meeting of stockholders to approve amendments to the Company\u2019s amended and restated certificate of incorporation to effect a reverse stock split of the Company\u2019s common stock at a ratio ranging from any whole number between 1-for-10 and 1-for-25, as determined by the board of directors in its discretion.", "snippet_links": [{"key": "the-proposal", "type": "clause", "offset": [6, 18]}, {"key": "annual-meeting-of-stockholders", "type": "definition", "offset": [57, 87]}, {"key": "to-approve", "type": "clause", "offset": [88, 98]}, {"key": "to-the-company", "type": "clause", "offset": [110, 124]}, {"key": "amended-and-restated-certificate-of-incorporation", "type": "definition", "offset": [127, 176]}, {"key": "reverse-stock-split", "type": "clause", "offset": [189, 208]}, {"key": "of-the-company", "type": "clause", "offset": [209, 223]}, {"key": "common-stock", "type": "clause", "offset": [226, 238]}, {"key": "whole-number", "type": "definition", "offset": [267, 279]}, {"key": "by-the-board-of-directors", "type": "clause", "offset": [325, 350]}, {"key": "in-its-discretion", "type": "clause", "offset": [351, 368]}], "hash": "2805a1ca1426086be232acf168d05e13", "id": 2}, {"size": 4, "samples": [{"hash": "7qjsEkRa5wa", "uri": "https://www.sec.gov/Archives/edgar/data/1620179/000110465923031828/tm239068d1_ex3-3.htm", "label": "Exela Technologies, Inc.", "score": 18.1937026978, "published": false}, {"hash": "huqxDWn8vLT", "uri": "https://investors.exelatech.com/static-files/992f9611-500c-4f93-868b-e0c57dc2e69b", "label": "investors.exelatech.com", "score": 11.9240245819, "published": false}], "snippet": "means the proposal to adopt the Reverse Stock Split Amendment submitted for Stockholder Approval at the Special Meeting.", "snippet_links": [{"key": "the-proposal", "type": "clause", "offset": [6, 18]}, {"key": "reverse-stock-split-amendment", "type": "definition", "offset": [32, 61]}, {"key": "stockholder-approval", "type": "definition", "offset": [76, 96]}, {"key": "the-special-meeting", "type": "clause", "offset": [100, 119]}], "hash": "8f03dfbccc720de34b6eafa6963ef1f3", "id": 3}, {"size": 4, "samples": [{"hash": "1nuAFBn1WNU", "uri": "/contracts/1nuAFBn1WNU#reverse-stock-split-proposal", "label": "Merger Agreement (Apimeds Pharmaceuticals US, Inc.)", "score": 36.9397672827, "published": true}, {"hash": "fNPLQMu1JOa", "uri": "/contracts/fNPLQMu1JOa#reverse-stock-split-proposal", "label": "Merger Agreement (Apimeds Pharmaceuticals US, Inc.)", "score": 36.9178657532, "published": true}], "snippet": "has the meaning specified in the Recitals.", "snippet_links": [{"key": "the-recitals", "type": "clause", "offset": [29, 41]}], "hash": "4454881ba8e5519ee01e4b77fdc19946", "id": 4}, {"size": 3, "samples": [{"hash": "5lhMuIzNcTJ", "uri": "https://investor.inspirato.com/static-files/08a707e3-7601-48dc-bfc0-644cb65cfc36", "label": "investor.inspirato.com", "score": 19.57289505, "published": false}, {"hash": "7YLY0UjsZy4", "uri": "https://investor.inspirato.com/static-files/65cd1189-5db5-4c81-8b9d-6decd9c8d5c5", "label": "investor.inspirato.com", "score": 19.2627792358, "published": false}, {"hash": "eMvbQbKAJAB", "uri": "https://investor.inspirato.com/static-files/36b32329-fd13-4bb0-a080-f812f2d4bbcb", "label": "investor.inspirato.com", "score": 19.2588233948, "published": false}], "snippet": "means the proposal to adopt, authorize and approve the reverse stock split of the outstanding shares of the Company Common Stock as presented to the Company\u2019s stockholders at the Company Special Meeting by the combination of each five (5), ten (10), fifteen (15) or twenty (20) (with the effective number to be determined by the Board of Directors following approval of the Reverse Stock Split Proposal by the Company\u2019s stockholders) shares of Company Class A Common Stock, and of Company Class V Common Stock, into one (1) share of Company", "snippet_links": [{"key": "the-proposal", "type": "clause", "offset": [6, 18]}, {"key": "the-reverse-stock-split", "type": "clause", "offset": [51, 74]}, {"key": "the-company-common-stock", "type": "clause", "offset": [104, 128]}, {"key": "to-the-company", "type": "clause", "offset": [142, 156]}, {"key": "the-company-special-meeting", "type": "clause", "offset": [175, 202]}, {"key": "the-combination", "type": "clause", "offset": [206, 221]}, {"key": "to-be-determined", "type": "definition", "offset": [305, 321]}, {"key": "by-the-board-of-directors", "type": "clause", "offset": [322, 347]}, {"key": "approval-of", "type": "definition", "offset": [358, 369]}, {"key": "by-the-company", "type": "clause", "offset": [403, 417]}, {"key": "company-class-a-common-stock", "type": "clause", "offset": [444, 472]}, {"key": "company-class-v-common-stock", "type": "definition", "offset": [481, 509]}], "hash": "d2e3e406800eb7f3192d87d1382edae7", "id": 5}, {"size": 2, "samples": [{"hash": "i1cPBG5yhej", "uri": "https://www.sec.gov/Archives/edgar/data/1282980/000199937124000104/ex3-1.htm", "label": "Certificate of Incorporation (Dror Ortho-Design, Inc.)", "score": 23.0068454742, "published": false}, {"hash": "64OSk7q4Im8", "uri": "https://www.sec.gov/Archives/edgar/data/1282980/000138713123009791/ex3-2.htm", "label": "Novint Technologies Inc", "score": 16.6153316498, "published": false}], "snippet": "means a proposal to amend the Corporation\u2019s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the outstanding shares of Common Stock one or more times at an aggregate ratio of between one for one thousand (1:1,000) and one for one hundred thousand (1:100,000) with the specific ratio to be determined by the Board of Directors in its reasonable discretion.", "snippet_links": [{"key": "a-proposal", "type": "clause", "offset": [6, 16]}, {"key": "to-amend", "type": "definition", "offset": [17, 25]}, {"key": "the-corporation", "type": "clause", "offset": [26, 41]}, {"key": "amended-and-restated-certificate-of-incorporation", "type": "definition", "offset": [44, 93]}, {"key": "reverse-stock-split", "type": "clause", "offset": [106, 125]}, {"key": "outstanding-shares-of-common-stock", "type": "definition", "offset": [133, 167]}, {"key": "ratio-of", "type": "clause", "offset": [202, 210]}, {"key": "to-be-determined", "type": "definition", "offset": [319, 335]}, {"key": "by-the-board-of-directors", "type": "clause", "offset": [336, 361]}, {"key": "reasonable-discretion", "type": "clause", "offset": [369, 390]}], "hash": "44555f553aef524bf04823b3533af490", "id": 6}, {"size": 2, "samples": [{"hash": "dfEIWl7P2ss", "uri": "https://www.sec.gov/Archives/edgar/data/1860657/000121390023045091/ea179534ex3-1_allarity.htm", "label": "Certificate of Amendment (Allarity Therapeutics, Inc.)", "score": 20.4127311707, "published": false}, {"hash": "aITNpyr3ade", "uri": "https://d18rn0p25nwr6d.cloudfront.net/CIK-0001860657/d9b1c660-e96c-45cb-be3b-edc1cac231c1.pdf", "label": "Certificate of Amendment", "score": 14.0171117783, "published": false}], "snippet": "means the proposal to approve a reverse stock split of the Corporation\u2019s issued and outstanding Common Stock that, subject to the affirmative vote or consent of the Holders of a majority of the then outstanding shares of the Series A Preferred Stock, is effected by the Corporation, following the next meeting of the Corporation\u2019s stockholders after the date hereof, by the filing of the Amendment with and acceptance by the Secretary of State of the State of Delaware.", "snippet_links": [{"key": "the-proposal", "type": "clause", "offset": [6, 18]}, {"key": "to-approve", "type": "clause", "offset": [19, 29]}, {"key": "reverse-stock-split", "type": "clause", "offset": [32, 51]}, {"key": "of-the-corporation", "type": "clause", "offset": [52, 70]}, {"key": "outstanding-common-stock", "type": "definition", "offset": [84, 108]}, {"key": "subject-to-the", "type": "clause", "offset": [115, 129]}, {"key": "affirmative-vote", "type": "definition", "offset": [130, 146]}, {"key": "holders-of", "type": "clause", "offset": [165, 175]}, {"key": "a-majority", "type": "clause", "offset": [176, 186]}, {"key": "shares-of", "type": "clause", "offset": [211, 220]}, {"key": "series-a-preferred-stock", "type": "clause", "offset": [225, 249]}, {"key": "by-the-corporation", "type": "clause", "offset": [263, 281]}, {"key": "following-the", "type": "definition", "offset": [283, 296]}, {"key": "date-hereof", "type": "clause", "offset": [354, 365]}, {"key": "the-amendment", "type": "clause", "offset": [384, 397]}, {"key": "secretary-of-state-of-the-state-of-delaware", "type": "clause", "offset": [425, 468]}], "hash": "4c7cd3844dac322847aa6edf1f63683e", "id": 7}, {"size": 2, "samples": [{"hash": "fM1LuHz9AtO", "uri": "/contracts/fM1LuHz9AtO#reverse-stock-split-proposal", "label": "Securities Purchase Agreement (Outlook Therapeutics, Inc.)", "score": 35.0616035461, "published": true}, {"hash": "aAvk2nlI2IO", "uri": "/contracts/aAvk2nlI2IO#reverse-stock-split-proposal", "label": "Securities Purchase Agreement (Outlook Therapeutics, Inc.)", "score": 35.0616035461, "published": true}], "snippet": "has the meaning ascribed to such term in Section 4.6(b).", "snippet_links": [], "hash": "e279e60e7afd549a664da3dcf69c6996", "id": 8}, {"size": 2, "samples": [{"hash": "fjWEdZeLQdC", "uri": "/contracts/fjWEdZeLQdC#reverse-stock-split-proposal", "label": "Investment Agreement (Inspirato Inc)", "score": 34.598903656, "published": true}, {"hash": "8lJuuec5quL", "uri": "/contracts/8lJuuec5quL#reverse-stock-split-proposal", "label": "Investment Agreement (Inspirato Inc)", "score": 34.598903656, "published": true}], "snippet": "means the proposal to adopt, authorize and approve the reverse stock split of the outstanding shares of the Company Common Stock as presented to the Company\u2019s stockholders at the Company Special Meeting by the combination of each five (5), ten (10), fifteen (15) or twenty (20) (with the effective number to be determined by the Board of Directors following approval of the Reverse Stock Split Proposal by the Company\u2019s stockholders) shares of Company Class A Common Stock, and of Company Class V Common Stock, into one (1) share of Company Class A Common Stock and one (1) share of Company Class V Common Stock, respectively (each such proposed reverse stock split ratio, a \u201cProposed Reverse Stock Split Ratio\u201d). For the avoidance of doubt, following the reverse stock split, one share of Company Class A Common Stock shall continue to be identical in all respects to one share of Company Class B Non-Voting Common Stock except as expressly set forth in the Amendment to the Charter.", "snippet_links": [{"key": "the-proposal", "type": "clause", "offset": [6, 18]}, {"key": "the-reverse-stock-split", "type": "clause", "offset": [51, 74]}, {"key": "the-company-common-stock", "type": "clause", "offset": [104, 128]}, {"key": "to-the-company", "type": "clause", "offset": [142, 156]}, {"key": "the-company-special-meeting", "type": "clause", "offset": [175, 202]}, {"key": "the-combination", "type": "clause", "offset": [206, 221]}, {"key": "to-be-determined", "type": "definition", "offset": [305, 321]}, {"key": "by-the-board-of-directors", "type": "clause", "offset": [322, 347]}, {"key": "approval-of", "type": "definition", "offset": [358, 369]}, {"key": "by-the-company", "type": "clause", "offset": [403, 417]}, {"key": "company-class-a-common-stock", "type": "clause", "offset": [444, 472]}, {"key": "company-class-v-common-stock", "type": "definition", "offset": [481, 509]}, {"key": "reverse-stock-split-ratio", "type": "definition", "offset": [646, 671]}, {"key": "for-the-avoidance-of-doubt", "type": "clause", "offset": [714, 740]}, {"key": "following-the", "type": "definition", "offset": [742, 755]}, {"key": "one-share", "type": "definition", "offset": [777, 786]}, {"key": "stock-shall", "type": "definition", "offset": [813, 824]}, {"key": "in-all-respects", "type": "clause", "offset": [850, 865]}, {"key": "class-b", "type": "clause", "offset": [890, 897]}, {"key": "voting-common-stock", "type": "clause", "offset": [902, 921]}, {"key": "amendment-to-the-charter", "type": "definition", "offset": [959, 983]}], "hash": "81ccc93a8a7e520043a4210025c07de0", "id": 9}, {"size": 1, "samples": [{"hash": "1DwIS6Hkzjq", "uri": "/contracts/1DwIS6Hkzjq#reverse-stock-split-proposal", "label": "Securities Exchange Agreement (Arcadia Biosciences, Inc.)", "score": 33.9295005798, "published": true}], "snippet": "has the meaning set forth in Section 2.5.", "snippet_links": [], "hash": "fd85c2c1ffd623fd985f153487f37567", "id": 10}], "next_curs": "CmkSY2oVc35sYXdpbnNpZGVyY29udHJhY3RzckULEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIlcmV2ZXJzZS1zdG9jay1zcGxpdC1wcm9wb3NhbCMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"size": 36, "title": "Reverse Stock Split Proposal", "snippet": "means a proposal to amend the Corporation\u2019s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the outstanding shares of Common Stock at a ratio of between one for thirty (1:30) and one for sixty (1:60) with the specific ratio to be determined by the Board of Directors in its reasonable discretion, primarily for the purpose of satisfying any minimum bid price or closing price requirements applicable to the Common Stock in connection with the Uplisting.", "id": "reverse-stock-split-proposal", "examples": ["The Share Increase Proposal and <strong>Reverse Stock Split Proposal</strong> require the affirmative vote of the holders of at least a majority of the voting power of the outstanding shares of Era Common Stock entitled to vote.", "For the avoidance of doubt, if the <strong>Reverse Stock Split Proposal</strong> is approved by the Company\u2019s stockholders and the related amendment to the Company\u2019s certificate of incorporation becomes effective, the Conversion Price shall be adjusted for the applicable Reverse Stock Split Ratio.", "Subject to receipt of the requisite stockholder approval of the <strong>Reverse Stock Split Proposal</strong>, the Company shall implement the Reverse Split Stock Split within five (5) Trading Days following the 2024 Stockholder Meeting.", "Homology shall submit to Homology\u2019s stockholders at the Homology Stockholder Meeting the <strong>Reverse Stock Split Proposal</strong>, and the Parties shall take such other actions as shall be reasonably necessary to effectuate the Nasdaq Reverse Split.", "Each of the Ensco <strong>Reverse Stock Split Proposal</strong>, the Ensco General Allotment Authority Proposal and the Ensco Transaction-Related Compensation Proposal will be proposed as an ordinary resolution and, assuming a quorum is present, each such proposal will be approved if a majority of the votes cast are cast in favor thereof.", "Assuming approval of the Stock Issuance Proposal, the Authorized Share Increase Proposal and the <strong>Reverse Stock Split Proposal</strong>, and successful application for initial listing with Nasdaq, following the consummation of the Merger, the Homology common stock will trade on Nasdaq under Homology\u2019s new name, \u201cQ32 Bio Inc.,\u201d and new trading symbol \u201cQTTB.\u201d As of February 5, 2024, the Record Date for the Homology Special Meeting, there were approximately 15 holders of record of the Homology common stock.", "Each Purchaser covenants to vote, and shall cause its Affiliates to vote, all shares of Common Stock and Series A-1 Preferred Stock owned by such Purchaser or its Affiliates, as applicable, in favor of the adoption of the <strong>Reverse Stock Split Proposal</strong> and, to the extent applicable, in favor of the Board Structure Proposal at any meeting of stockholders of the Company called and held for such purpose, or any adjournment or postponement thereof.", "At the request of the Company, each Purchaser covenants to vote all shares of Common Stock owned by such Purchaser in favor of the adoption of the <strong>Reverse Stock Split Proposal</strong> at any meeting of stockholders of the Company called and held for such purpose, or any adjournment or postponement thereof.", "The NTN board of directors recommends that NTN\u2019s stockholders vote \u201cFOR\u201d the <strong>Reverse Stock Split Proposal</strong>.", "Approval of an adjournment of the special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the Merger Share Issuance Proposal, the <strong>Reverse Stock Split Proposal</strong>, the Increase in Authorized Shares Proposal, the Series A Voting Rights Proposal, or the Asset Sale Proposal."], "related": [["reverse-stock-split-date", "Reverse Stock Split Date", "Reverse Stock Split Date"], ["reverse-stock-split", "Reverse Stock Split", "Reverse Stock Split"], ["company-acquisition-proposal", "Company Acquisition Proposal", "Company Acquisition Proposal"], ["reverse-split", "Reverse Split", "Reverse Split"], ["stock-split", "Stock Split", "Stock Split"]], "related_snippets": [], "updated": "2025-12-12T05:47:50+00:00"}, "json": true, "cursor": ""}}